Bahrain's National Health Regulatory Authority signed off on the oral GLP-1 version of Wegovy for treating obesity, per the state news agency.
Recap by typeshit. Post by Bahrain News Agency on Instagram.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Superpower frames apitegromab's FDA approval as a big step and ties it to concern that GLP-1 users can lose a lot of muscle along with fat.
The telehealth company is also adding blood testing services alongside the lower costs for its compounded GLP-1 options.
Huberman says verified, US-made sourcing would change the peptide market, and wonders which compounds beyond GLPs would qualify.
Compounded semaglutide and tirzepatide now cost less at lower starting doses, and members can order cholesterol, A1C and thyroid panels in the same app.
Pricing now scales with dose, so people on lower starting doses pay less. The new Mochi Labs bloodwork service tracks A1C, cholesterol and thyroid, though not in NY, NJ, RI or HI.
Loading…